Linganisha mbinu

	Uchambuzi wa Tofauti ya Idadi ya Nakala kwa Msaada wa Kujifunza kwa Mashine	Genome-wide association study
Nyanja	Bioinformatiki	Bioinformatiki
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2010s–present	2005–2007
Mwanzilishi	Multiple groups; notable early ML-CNV tools include CNV-RF (Bellos et al., 2014) and CANOES (Backenroth et al., 2014)	Klein et al. (age-related macular degeneration GWAS, 2005); landmark scale: Wellcome Trust Case Control Consortium (2007)
Aina	Supervised/unsupervised machine learning pipeline for genomic structural variant detection	Observational genomic association study
Chanzo asilia	Aganezov, S., Goodwin, S., Sherman, R. M., Sedlazeck, F. J., Mehta, G., Rushbrook, S., ... & Schatz, M. C. (2020). Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. Genome Research, 30(9), 1258-1273.	Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661–678.
Majina mbadala	ML-CNV analysis, ML-based CNV calling, machine learning CNV detection, deep learning CNV analysis	GWAS, genome-wide association analysis, whole-genome association study, WGAS
Zinazohusiana	6	6
Muhtasari	Machine learning-assisted CNV analysis applies supervised, unsupervised, or deep learning algorithms to detect genomic regions that are duplicated or deleted relative to a reference genome. Rather than relying on fixed statistical thresholds, ML models learn discriminative patterns from read-depth signals, allele frequencies, and other features, substantially improving sensitivity and specificity over classical tools — especially in noisy or low-coverage sequencing data.	A genome-wide association study (GWAS) systematically tests hundreds of thousands to millions of single-nucleotide polymorphisms (SNPs) across the human genome for statistical association with a trait or disease. By comparing allele frequencies between cases and controls — or by regressing SNP genotypes on a quantitative phenotype — GWAS identifies genomic loci that harbor common genetic variants contributing to complex traits. Since its large-scale debut in 2007, GWAS has catalogued thousands of robust disease–variant associations across virtually every common human condition.